Newsfeeds - Spark Newswire - Page 2

Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Read More

2 minute read

Cellectis Publishes Manuscript In Frontiers Bioengineering And Biotechnology Unveiling Efficient Multitool/Multiplex Gene Engineering combining TALEN And TALE Base Editors

By Benzinga Newsdesk

Today, 9:47 AM

Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today published a manuscript

Read More

31 minute read

Earnings

Earnings Scheduled For November 3, 2022

By Benzinga Insights

Today, 9:47 AM

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

Read More

1 minute read

Earnings

Cellectis’s Earnings Outlook

By Benzinga Insights

Today, 9:47 AM

Cellectis (NASDAQ:CLLS) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Cellectis will report an earnings per share (EPS) of $-0.45.

Read More

25 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 9:47 AM

During Monday's session, 402 companies made new 52-week lows.

Read More

6 minute read

Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday

Today, 9:47 AM

Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.

Read More

1 minute read

Movers

11 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 9:47 AM

Gainers Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 30.46% to $0.59. The market value of their outstanding shares is at $53.5 million.

Read More

34 minute read

Earnings

Earnings Scheduled For August 4, 2022

By Benzinga Insights

Today, 9:47 AM

Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.

Read More

4 minute read

Recap Of Monday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

Today, 9:47 AM

The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application…

Read More

24 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 9:47 AM

On Friday, 422 stocks made new 52-week lows.

Read More

1 minute read

Goldman Sachs Maintains Sell on Cellectis, Lowers Price Target to $2

By Benzinga Newsdesk

Today, 9:47 AM

Goldman Sachs maintains Cellectis (NASDAQ:CLLS) with a Sell and lowers the price target from $3 to $2.